title: What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?
authors.forename: Sunil
authors.initials: S
authors.lastname: Verma
authors.forename: Maureen
authors.initials: M
authors.lastname: Trudeau
authors.forename: George
authors.initials: G
authors.lastname: Dranitsaris
authors.forename: Mark
authors.initials: M
authors.lastname: Clemons
authors.forename: Anil A
authors.initials: AA
authors.lastname: Joy
authors.forename: John R
authors.initials: JR
authors.lastname: MacKey
mesh_terms: D018943:Anthracyclines / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D009362:Neoplasm Metastasis; D011379:Prognosis; D012189:Retrospective Studies; D013534:Survival; D043823:Taxoids / Q000627:therapeutic use; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D018943:Anthracyclines; D043823:Taxoids; D003841:Deoxycytidine; D014747:Vinblastine; D000069287:Capecitabine; D000077235:Vinorelbine; D005472:Fluorouracil